A phase 3 study of ravulizumab to protect patients with chronic kidney disease from cardiac surgery-associated acute kidney injury and major adverse kidney events (ARTEMIS)
一项评估 ravulizumab 保护慢性肾病患者免受心脏手术相关急性肾损伤和重大肾脏不良事件的 3 期研究 (ARTEMIS)
期刊:Trials
影响因子:2
doi:10.1186/s13063-025-08895-7
Ostermann, Marlies; Corteville, David C; Doi, Kent; Koyner, Jay L; Lamy, Andre; Li, Gerry; Solinsky, Christine M; Winterberg, Pamela D; Smith, William T; Mehta, Ravindra L; Murray, Patrick T; Shaw, Andrew D; Zarbock, Alexander; Engelman, Daniel T